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Estimate Cohen's kappa statistics and test for the null hypoth
esis that the extent of agreement is same as random (kappa=
0) between PT cPRA values and each one of the calculators 
Calculator kappa 95% CI p-value 
CTR 0.47 0.26-0.68 <0.001 
UNOS 0.62 0.44-0.79 <0.001 
ET 0.67 0.50-0.84 <0.001 
PT Portuguese 
CTR Canadian Transplant Registry 
UNOS United Network for Organ Sharing 
ET Eurotransplant 
CI Confidence Interval 
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Calculated panel-reactive antibody (cPRA) is an accurate 
measure for the definition of candidates’ immunization to a 
transplant. Based upon unacceptable HLA antigens to which 
the patient has been sensitized, cPRA is computed with 
HLA allelic and haplotypic frequencies from a pool of 
possible donors and represents the percentage of donors that 
express one or more of the antigens unacceptable for  a 
given transplant candidate. The aim of this study is to 
compare cPRA values obtained from HLA frequencies of 
Portuguese donors with values obtained from cPRA 
calculators from international established sources. We 
randomly generate HLA-A, -B and -DRB1 unacceptable 
antigens to a simu- lated cohort of 100 transplant 
candidates. With the respective antigens for each patient we 
compute the Portu- guese (PT) cPRA values using the 
formula developed by Zachary and Braun based on HLA 
allelic and haplotypic frequencies of 37,993 unrelated bone 
marrow donors. The results obtained were compared with 
cPRA values defined from Canadian Transplant Registry 
(CTR), United Network for Organ Sharing (UNOS) and 
Eurotransplant (ET) calcula- tors. For each calculator we 
also classified cPRA between 0-19% as low sensitized, 
between 20-79% as sensitized and >79% as highly 
sensitized. Spearmans rho test was used to compare results 
from each calculator and to assess the correlation between 
them; Cohen's kappa coefficient was used to access 
agreement for categorical values. Values obtained for cPRA 
from PT calculator are highly correlated with cPRA 
obtained from each one of the three calculators. When we 
categorized cPRA values from each calculator, substantial 
agreement was obtained between PT and ET (kappa = 0.67) 
and between PT and UNOS (kappa = 0.62) while only a 
moderate agreement was obtained between PT and CTR 
values (kappa = 0.47). 
The cPRA gives us the probability of each transplant 
candidate to have a positive crossmatch with the next 
available donor for transplantation. Reliability of cPRA 
values depends on the donor pool from which it is 
calculated, and  it is crucial for highly sensitized patients to 
be classified as so. The genotypic frequencies used for 
cPRA computation frequencies should be known and 
scrutinized to assure a correct measure of candidates’ 
sensitization and must correspond, as far as possible, to 
those from future organ donors. 
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